Biogipuzkoa Health Research Institute
Clinical trials sponsored by Biogipuzkoa Health Research Institute, explained in plain language.
-
New combo therapy hopes to slow ALS progression
Disease control Recruiting nowThis study tests whether taking N-acetylcysteine (NAC) and EH-301 together with the standard drug riluzole can slow down amyotrophic lateral sclerosis (ALS). About 90 people with early-stage ALS will receive either the active combination or a placebo for 6 months. After that, eve…
Phase: PHASE1, PHASE2 • Sponsor: Biogipuzkoa Health Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Digital brain training may ease 'chemo brain' — a trial puts it to the test
Symptom relief Recruiting nowThis trial tests whether two types of home-based digital cognitive training can help cancer survivors who have memory, attention, or thinking problems after chemotherapy. Participants will use either a computer program (BrainHQ) or a virtual reality cognitive training for 10 week…
Phase: NA • Sponsor: Biogipuzkoa Health Research Institute • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
AI could spot hidden heart risks in menopausal women
Knowledge-focused Recruiting nowThis study aims to develop an artificial intelligence tool that can better predict a woman's risk of heart disease during the menopausal transition. Researchers will collect health data from 3,000 women aged 40 to 60 across Europe and Colombia, including blood tests, blood pressu…
Sponsor: Biogipuzkoa Health Research Institute • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC